VYNE Therapeutics  logo
VYNE Therapeutics VYNE
$ 2.49 4.18%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

VYNE Therapeutics ROA Ratio 2011-2024 | VYNE

Annual ROA Ratio VYNE Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-29.13 -56.95 -109.37 -272.63 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-29.13 -272.63 -117.02

Quarterly ROA Ratio VYNE Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-95.15 -119.5 -90.41 -110.58 -96.57 -71.63 -28.26 -54.44 -60.45 -59.96 -54.82 -81.19 -81.37 -245.12 -247.9 -274.39 -276.56 -121.35 -97.16 -83.25 -63.89 -46.45 -36.77 -38.07 -41.11 -44.34 -43.48 -41.11 -28.89 -19.69 -11.5 - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-11.5 -276.56 -89.21